1. Home
  2. GKOS vs CSW Comparison

GKOS vs CSW Comparison

Compare GKOS & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CSW
  • Stock Information
  • Founded
  • GKOS 1998
  • CSW 2014
  • Country
  • GKOS United States
  • CSW United States
  • Employees
  • GKOS N/A
  • CSW N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CSW Home Furnishings
  • Sector
  • GKOS Health Care
  • CSW Industrials
  • Exchange
  • GKOS Nasdaq
  • CSW Nasdaq
  • Market Cap
  • GKOS 5.4B
  • CSW 4.4B
  • IPO Year
  • GKOS 2015
  • CSW N/A
  • Fundamental
  • Price
  • GKOS $87.64
  • CSW $238.96
  • Analyst Decision
  • GKOS Strong Buy
  • CSW Hold
  • Analyst Count
  • GKOS 13
  • CSW 4
  • Target Price
  • GKOS $120.38
  • CSW $278.00
  • AVG Volume (30 Days)
  • GKOS 718.5K
  • CSW 136.3K
  • Earning Date
  • GKOS 10-29-2025
  • CSW 11-03-2025
  • Dividend Yield
  • GKOS N/A
  • CSW 0.45%
  • EPS Growth
  • GKOS N/A
  • CSW 19.18
  • EPS
  • GKOS N/A
  • CSW 8.37
  • Revenue
  • GKOS $432,953,000.00
  • CSW $915,770,000.00
  • Revenue This Year
  • GKOS $28.90
  • CSW $21.71
  • Revenue Next Year
  • GKOS $25.57
  • CSW $8.89
  • P/E Ratio
  • GKOS N/A
  • CSW $28.47
  • Revenue Growth
  • GKOS 26.70
  • CSW 12.27
  • 52 Week Low
  • GKOS $77.10
  • CSW $230.45
  • 52 Week High
  • GKOS $163.71
  • CSW $436.50
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.74
  • CSW 42.17
  • Support Level
  • GKOS $82.19
  • CSW $230.96
  • Resistance Level
  • GKOS $86.74
  • CSW $246.57
  • Average True Range (ATR)
  • GKOS 3.27
  • CSW 7.86
  • MACD
  • GKOS 0.56
  • CSW 0.09
  • Stochastic Oscillator
  • GKOS 82.87
  • CSW 28.03

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CSW CSW Industrials Inc. Common Stock

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.

Share on Social Networks: